湖北济川药业股份有限公司关于全资子公司开立募集资金现金管理专用结算账户并利用闲置募集资金进行现金管理的进展公告
Filed with SSE ·
On 6ix: 6ix.com/news/news-19
6ix hasn’t read this filing yet.
Hubei Jumpcan Pharmaceutical Co., Ltd on 6ix
Earlier from Hubei Jumpcan Pharmaceutical
- Announcement on Progress in Wholly-owned Subsidiaries Opening Special Settlement Account for Cash Management of Raised Funds and Using Idle Raised Funds for Cash Management
- Report for Q3 2025
- Announcement on Implementation of Independent Exercise in the 1st Exercise Period of Initially Granted Stock Options in 2022 Restricted Stock and Stock Option Incentive Plan
- Announcement on Lifting Trading Restrictions and Listing of the 1st Trade Restriction Release Period of Initially Granted Restricted Stock under the 2022 Restricted Stock and Stock Option Incentive Plan
- Announcement on Convening the 2025 Semi-annual Performance Briefing
Later from Hubei Jumpcan Pharmaceutical
- Announcement on Implementation of Repurchase and Cancellation of Partial Restricted Stocks under 2022 Restricted Stock and Stock Option Incentive Plan
- Announcement on Resolutions of the 19th Meeting of the 10th Board of Directors
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Limit Concerning Shares Repurchase
- Announcement on Self-exercise Results and Changes in Share Capital of 2022 Restricted Stock and Stock Option Incentive Plan in Q4 2025
- Announcement on Initially Repurchasing Shares through Call Auction
Follow Hubei Jumpcan Pharmaceutical into a list and get an email when it puts out news.
Follow Hubei Jumpcan Pharmaceutical